U2 Building, GSK Ware

Sectors: Pharmaceutical and Manufacturing

Client: GlaxoSmithKline

Construction Value: £12million

Involvement: RIBA stages 0-7


PROJECT:

The U2 building created a facility to support the respiratory product stream manufacturing asthmatic inhalers for the US market. The building forms phase 1 of a major new development and production facility.

A fast-track project, taking one year from inception to completion and product manufacture, the building was designed to enable fit out to progress in tandem with the external fabric and to allow work to progress at all levels.

FACILITIES AREA:

  • Ground Floor - 1200 sq m Production facility incorporating Class 10,000 Clean rooms and Class 100,000 packing and assembly hall

  • Mezzanine - : 350 sq m ancillary accommodation

  • First Floor - 1,000 sq m of Plant room, Designed to comply with FM standards.